{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T16:19:11Z","timestamp":1790353151277,"version":"4.1.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T00:00:00Z","timestamp":1733788800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ctro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical and Translational Radiation Oncology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.ctro.2024.100900","type":"journal-article","created":{"date-parts":[[2024,12,14]],"date-time":"2024-12-14T03:46:50Z","timestamp":1734148010000},"page":"100900","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Radiotherapy-induced Hypothalamic-Pituitary axis dysfunction in adult Brain, head and neck and skull base tumor patients \u2013 A systematic review and Meta-Analysis"],"prefix":"10.1016","volume":"51","author":[{"given":"J.M.J.","family":"Paulissen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.M.L.","family":"Zegers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.M.","family":"Houben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Hofstede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Kars","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.M.","family":"van Santen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.J.P.","family":"Hoebers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.K.M. De","family":"Ruysscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.B.P.","family":"Eekers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10318","key":"10.1016\/j.ctro.2024.100900_b0005","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1016\/S0140-6736(21)01550-6","article-title":"Head and neck cancer","volume":"398","author":"Mody","year":"2021","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ctro.2024.100900_b0010","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/s41571-020-00447-z","article-title":"EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood","volume":"18","author":"Weller","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"issue":"5","key":"10.1016\/j.ctro.2024.100900_b0015","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/s41571-022-00623-3","article-title":"Author Correction: EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood","volume":"19","author":"Weller","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2024.100900_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2017.12.013","article-title":"The EPTN consensus-based atlas for CT- and MR-based contouring in neuro-oncology","volume":"128","author":"Eekers","year":"2018","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2024.100900_b0025","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.radonc.2018.05.001","article-title":"Radiation dose constraints for organs at risk in neuro-oncology; the European Particle Therapy Network consensus","volume":"128","author":"Lambrecht","year":"2018","journal-title":"Radiother Oncol"},{"issue":"6","key":"10.1016\/j.ctro.2024.100900_b0030","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s11912-022-01214-2","article-title":"Functional Outcomes and Quality of Life in Patients with Sinonasal, Nasopharyngeal, and Anterior Skull Base Tumors","volume":"24","author":"Jozaghi","year":"2022","journal-title":"Curr Oncol Rep"},{"issue":"7","key":"10.1016\/j.ctro.2024.100900_b0035","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/S2213-8587(15)00008-X","article-title":"Effect of cancer treatment on hypothalamic-pituitary function","volume":"3","author":"Crowne","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"4","key":"10.1016\/j.ctro.2024.100900_b0040","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1677\/erc.1.00779","article-title":"The impact of cancer therapy on the endocrine system in survivors of childhood brain tumours","volume":"11","author":"Gleeson","year":"2004","journal-title":"Endocr Relat Cancer"},{"issue":"2","key":"10.1016\/j.ctro.2024.100900_b0045","doi-asserted-by":"crossref","first-page":"82","DOI":"10.6065\/apem.2017.22.2.82","article-title":"Metabolic syndrome induced by anticancer treatment in childhood cancer survivors","volume":"22","author":"Chueh","year":"2017","journal-title":"Ann Pediatr Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.ctro.2024.100900_b0050","doi-asserted-by":"crossref","DOI":"10.1530\/EC-22-0298","article-title":"The late effects of cranial irradiation in childhood on the hypothalamic-pituitary axis: a radiotherapist\u2019s perspective","volume":"11","author":"L\u00f6vgren","year":"2022","journal-title":"Endocr Connect"},{"issue":"12","key":"10.1016\/j.ctro.2024.100900_b0055","doi-asserted-by":"crossref","first-page":"6101","DOI":"10.1210\/jc.2019-00834","article-title":"Hypothalamic-Pituitary Disorders in Childhood Cancer Survivors: Prevalence, Risk Factors and Long-Term Health Outcomes","volume":"104","author":"van Iersel","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.ctro.2024.100900_b0060","first-page":"475","article-title":"Surveillance of long-term complications after treatment of adult brain tumor survivors-review and evidence-based recommendations","volume":"9","author":"Figuracion","year":"2022","journal-title":"Neurooncol Pract"},{"issue":"8","key":"10.1016\/j.ctro.2024.100900_b0065","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2011-0306","article-title":"Pituitary dysfunction in adult patients after cranial radiotherapy: systematic review and meta-analysis","volume":"96","author":"Appelman-Dijkstra","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ctro.2024.100900_b0070","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3389\/fonc.2014.00073","article-title":"Effect of treatment modality on the hypothalamic-pituitary function of patients treated with radiation therapy for pituitary adenomas: hypothalamic dose and endocrine outcomes","volume":"4","author":"Elson","year":"2014","journal-title":"Front Oncol"},{"key":"10.1016\/j.ctro.2024.100900_b0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v036.i03","article-title":"Conducting Meta-Analyses in R with the metafor Package","volume":"36","author":"Viechtbauer","year":"2010","journal-title":"J Stat Soft"},{"issue":"9","key":"10.1016\/j.ctro.2024.100900_b0080","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1111\/j.1537-2995.2012.03687.x","article-title":"Prevalence versus incidence","volume":"52","author":"Enticott","year":"2012","journal-title":"Transfusion"},{"issue":"1048","key":"10.1016\/j.ctro.2024.100900_b0085","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20140413","article-title":"Use of gEUD for predicting ear and pituitary gland damage following proton and photon radiation therapy","volume":"88","author":"De Marzi","year":"2015","journal-title":"Br J Radiol"},{"key":"10.1016\/j.ctro.2024.100900_b0090","article-title":"Examination of the Dose-Effect Relationship of Radiation-Induced Hypopituitarism: Results of a Case-Control Study","volume":"6","author":"Vakilian","year":"2021","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.ctro.2024.100900_b0095","doi-asserted-by":"crossref","unstructured":"S. Huang, X. Wang, C. Hu, and H. Ying, \u201cHypothalamic-pituitary-thyroid dysfunction induced by intensity-modulated radiotherapy (IMRT) for adult patients with nasopharyngeal carcinoma,\u201d Med Oncol, vol. 30, no. 4, Art. no. 4, Dec. 2013, doi: 10.1007\/s12032-013-0710-9.","DOI":"10.1007\/s12032-013-0710-9"},{"key":"10.1016\/j.ctro.2024.100900_b0100","doi-asserted-by":"crossref","unstructured":"N. Kyriakakis et al., \u201cHypothalamic-pituitary axis irradiation dose thresholds for the development of hypopituitarism in adult-onset gliomas,\u201d Clin Endocrinol (Oxf), vol. 91, no. 1, Art. no. 1, Jul. 2019, doi: 10.1111\/cen.13971.","DOI":"10.1111\/cen.13971"},{"key":"10.1016\/j.ctro.2024.100900_b0105","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.radonc.2019.04.027","article-title":"Long-term outcomes and late adverse effects of a prospective study on proton radiotherapy for patients with low-grade glioma","volume":"137","author":"Tabrizi","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2024.100900_b0110","doi-asserted-by":"crossref","unstructured":"S. Madaschi et al., \u201cTime course of hypothalamic-pituitary deficiency in adults receiving cranial radiotherapy for primary extrasellar brain tumors,\u201d Radiother Oncol, vol. 99, no. 1, Art. no. 1, Apr. 2011, doi: 10.1016\/j.radonc.2011.02.015.","DOI":"10.1016\/j.radonc.2011.02.015"},{"key":"10.1016\/j.ctro.2024.100900_b0115","doi-asserted-by":"crossref","unstructured":"H. A. Shih et al., \u201cProton therapy for low-grade gliomas: Results from a prospective trial,\u201d Cancer, vol. 121, no. 10, Art. no. 10, May 2015, doi: 10.1002\/cncr.29237.","DOI":"10.1002\/cncr.29237"},{"key":"10.1016\/j.ctro.2024.100900_b0120","doi-asserted-by":"crossref","unstructured":"N. Kyriakakis et al., \u201cPituitary dysfunction following cranial radiotherapy for adult-onset nonpituitary brain tumours,\u201d Clin Endocrinol (Oxf), vol. 84, no. 3, Art. no. 3, Mar. 2016, doi: 10.1111\/cen.12969.","DOI":"10.1111\/cen.12969"},{"key":"10.1016\/j.ctro.2024.100900_b0125","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.radonc.2018.10.014","article-title":"Are hypothyroidism and hypogonadism clinically relevant in patients with malignant gliomas? A longitudinal trial in patients with glioma","volume":"130","author":"Handisurya","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2024.100900_b0130","doi-asserted-by":"crossref","unstructured":"J. Ratnasingam et al., \u201cHypothalamic pituitary dysfunction amongst nasopharyngeal cancer survivors,\u201d Pituitary, vol. 18, no. 4, Art. no. 4, Aug. 2015, doi: 10.1007\/s11102-014-0593-6.","DOI":"10.1007\/s11102-014-0593-6"},{"key":"10.1016\/j.ctro.2024.100900_b0135","doi-asserted-by":"crossref","unstructured":"N. M. Appelman-Dijkstra, F. Malgo, K. J. Neelis, I. Coremans, N. R. Biermasz, and A. M. Pereira, \u201cPituitary dysfunction in adult patients after cranial irradiation for head and nasopharyngeal tumours,\u201d Radiother Oncol, vol. 113, no. 1, Art. no. 1, Oct. 2014, doi: 10.1016\/j.radonc.2014.08.018.","DOI":"10.1016\/j.radonc.2014.08.018"},{"key":"10.1016\/j.ctro.2024.100900_b0140","doi-asserted-by":"crossref","unstructured":"P. Raymond, M. Klein, T. Cuny, O. Klein, J. Salleron, and V. Bernier-Chastagner, \u201cHigh prevalence of anterior pituitary deficiencies after cranial radiation therapy for skull base meningiomas,\u201d BMC Cancer, vol. 21, no. 1, Art. no. 1, Dec. 2021, doi: 10.1186\/s12885-021-09045-3.","DOI":"10.1186\/s12885-021-09045-3"},{"key":"10.1016\/j.ctro.2024.100900_b0145","doi-asserted-by":"crossref","unstructured":"E. Partoune, M. Virzi, L. Vander Veken, L. Renard, and D. Maiter, \u201cOccurrence of pituitary hormone deficits in relation to both pituitary and hypothalamic doses after radiotherapy for skull base meningioma,\u201d Clin Endocrinol (Oxf), May 2021, doi: 10.1111\/cen.14499.","DOI":"10.1111\/cen.14499"},{"issue":"10","key":"10.1016\/j.ctro.2024.100900_b0150","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1002\/hed.27476","article-title":"Prevalence of pituitary hormone dysfunction following radiotherapy for sinonasal and nasopharyngeal malignancies","volume":"45","author":"Contrera","year":"2023","journal-title":"Head Neck"},{"key":"10.1016\/j.ctro.2024.100900_b0155","doi-asserted-by":"crossref","unstructured":"L. J. McDowell et al., \u201cLong-Term Late Toxicity, Quality of Life, and Emotional Distress in Patients With Nasopharyngeal Carcinoma Treated With Intensity Modulated Radiation Therapy,\u201d Int J Radiat Oncol Biol Phys, vol. 102, no. 2, Art. no. 2, Oct. 2018, doi: 10.1016\/j.ijrobp.2018.05.060.","DOI":"10.1016\/j.ijrobp.2018.05.060"},{"key":"10.1016\/j.ctro.2024.100900_b0160","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.radonc.2020.07.029","article-title":"A multidimensional cohort study of late toxicity after intensity modulated radiotherapy for sinonasal cancer","volume":"151","author":"Sharma","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2024.100900_b0165","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1748-717X-6-36","article-title":"Fractionated stereotactic conformal radiotherapy for large benign skull base meningiomas","volume":"6","author":"Minniti","year":"2011","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ctro.2024.100900_b0170","doi-asserted-by":"crossref","unstructured":"G. Ntali and N. Karavitaki, \u201cEfficacy and complications of pituitary irradiation,\u201d Endocrinol Metab Clin North Am, vol. 44, no. 1, Art. no. 1, Mar. 2015, doi: 10.1016\/j.ecl.2014.10.009.","DOI":"10.1016\/j.ecl.2014.10.009"},{"key":"10.1016\/j.ctro.2024.100900_b0175","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ibror.2018.11.008","article-title":"The human hypothalamus in mood disorders: The HPA axis in the center","volume":"6","author":"Bao","year":"2019","journal-title":"IBRO Rep"},{"issue":"10","key":"10.1016\/j.ctro.2024.100900_b0180","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.3390\/brainsci11101298","article-title":"HPA Axis in the Pathomechanism of Depression and Schizophrenia: New Therapeutic Strategies Based on Its Participation","volume":"11","author":"Mikulska","year":"2021","journal-title":"Brain Sci"},{"issue":"4","key":"10.1016\/j.ctro.2024.100900_b0185","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/mp.2016.120","article-title":"HPA axis in major depression: cortisol, clinical symptomatology and genetic variation predict cognition","volume":"22","author":"Keller","year":"2017","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.ctro.2024.100900_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2020.109929","article-title":"Hypothalamic-pituitary-adrenal axis-related genes and cognition in major mood disorders and schizophrenia: a systematic review","volume":"101","author":"Ferrer","year":"2020","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"Suppl 1","key":"10.1016\/j.ctro.2024.100900_b0195","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/1520-6394(2000)12:1+<2::AID-DA2>3.0.CO;2-4","article-title":"Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders","volume":"12","author":"Ressler","year":"2000","journal-title":"Depress Anxiety"},{"issue":"1","key":"10.1016\/j.ctro.2024.100900_b0200","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s13014-023-02324-2","article-title":"Neurocognition and mean radiotherapy dose to vulnerable brain structures: new organs at risk?","volume":"18","author":"S\u00f6derstr\u00f6m","year":"2023","journal-title":"Radiat Oncol"},{"issue":"3","key":"10.1016\/j.ctro.2024.100900_b0205","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s11060-012-0859-7","article-title":"Sleep dysfunction in long term survivors of craniopharyngioma","volume":"108","author":"Manley","year":"2012","journal-title":"J Neurooncol"},{"issue":"4","key":"10.1016\/j.ctro.2024.100900_b0210","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S0936-6555(98)80011-3","article-title":"Somnolence syndrome in adults following cranial irradiation for primary brain tumours","volume":"10","author":"Faithfull","year":"1998","journal-title":"Clin Oncol (r Coll Radiol)"},{"issue":"1","key":"10.1016\/j.ctro.2024.100900_b0215","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.radonc.2011.06.028","article-title":"Somnolence syndrome in patients receiving radical radiotherapy for primary brain tumours: a prospective study","volume":"100","author":"Powell","year":"2011","journal-title":"Radiother Oncol"},{"issue":"7","key":"10.1016\/j.ctro.2024.100900_b0220","doi-asserted-by":"crossref","first-page":"937","DOI":"10.2174\/1871527311201070937","article-title":"Radiation-induced neuroinflammation and radiation somnolence syndrome","volume":"11","author":"Ballesteros-Zebad\u00faa","year":"2012","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"10.1016\/j.ctro.2024.100900_b0225","doi-asserted-by":"crossref","unstructured":"R. A. Berg, L. T. Ch\u2019ien, W. Lancaster, S. Williams, and J. Cummins, \u201cNeuropsychological sequelae of postradiation somnolence syndrome,\u201d J Dev Behav Pediatr, vol. 4, no. 2, pp. 103\u2013107, Jun. 1983, doi: 10.1097\/00004703-198306000-00005.","DOI":"10.1097\/00004703-198306000-00005"},{"issue":"6","key":"10.1016\/j.ctro.2024.100900_b0230","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1007\/BF03344141","article-title":"Hypopituitarism findings in patients with primary brain tumors 1 year after neurosurgical treatment: preliminary report","volume":"29","author":"De Marinis","year":"2006","journal-title":"J Endocrinol Invest"},{"issue":"4","key":"10.1016\/j.ctro.2024.100900_b0235","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1530\/eje.1.02272","article-title":"Endocrine dysfunction in patients operated on for non-pituitary intracranial tumors","volume":"155","author":"Schneider","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ctro.2024.100900_b0240","doi-asserted-by":"crossref","unstructured":"T. S. Han and H. K. Gleeson, \u201cLong-term and late treatment consequences: endocrine and metabolic effects,\u201d Curr Opin Support Palliat Care, vol. 11, no. 3, Art. no. 3, Sep. 2017, doi: 10.1097\/SPC.0000000000000289.","DOI":"10.1097\/SPC.0000000000000289"},{"issue":"5","key":"10.1016\/j.ctro.2024.100900_b0245","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1210\/endrev\/bnab040","article-title":"Hypothalamic-Pituitary and Other Endocrine Surveillance Among Childhood Cancer Survivors","volume":"43","author":"van Iersel","year":"2022","journal-title":"Endocr Rev"},{"issue":"12","key":"10.1016\/j.ctro.2024.100900_b0250","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.clon.2014.06.014","article-title":"Neurocognitive function after (chemo)-radiotherapy for head and neck cancer","volume":"26","author":"Welsh","year":"2014","journal-title":"Clin Oncol (r Coll Radiol)"},{"issue":"6","key":"10.1016\/j.ctro.2024.100900_b0255","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1080\/17446651.2019.1701434","article-title":"Hypophysitis induced by immune checkpoint inhibitors: a 10-year assessment","volume":"14","author":"Di Dalmazi","year":"2019","journal-title":"Expert Rev Endocrinol Metab"},{"key":"10.1016\/j.ctro.2024.100900_b0260","doi-asserted-by":"crossref","unstructured":"T. Sathyapalan and S. Dixit, \u201cRadiotherapy-induced hypopituitarism: a review,\u201d Expert Rev Anticancer Ther, vol. 12, no. 5, Art. no. 5, May 2012, doi: 10.1586\/era.12.27.","DOI":"10.1586\/era.12.27"},{"key":"10.1016\/j.ctro.2024.100900_b0265","doi-asserted-by":"crossref","unstructured":"K. H. Darzy, \u201cRadiation-Induced Hypopituitarism,\u201d Curr Opin Endocrinol Diabetes Obes, vol. 20, no. 4, Art. no. 4, Aug. 2013, doi: 10.1097\/MED.0b013e3283631820.","DOI":"10.1097\/MED.0b013e3283631820"},{"key":"10.1016\/j.ctro.2024.100900_b0270","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.radonc.2022.01.018","article-title":"The European Particle Therapy Network (EPTN) consensus on the follow-up of adult patients with brain and skull base tumours treated with photon or proton irradiation","volume":"168","author":"De Roeck","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2024.100900_b0275","doi-asserted-by":"crossref","unstructured":"J. Gebauer, P. Mehta, F. B. Fahlbusch, S. M. Schmid, D. Rades, and S. Janssen, \u201cHypothalamic-Pituitary Axis Dysfunction after Whole Brain Radiotherapy - A Cohort Study,\u201d Anticancer Res, vol. 40, no. 10, Art. no. 10, Oct. 2020, doi: 10.21873\/anticanres.14595.","DOI":"10.21873\/anticanres.14595"},{"key":"10.1016\/j.ctro.2024.100900_b0280","doi-asserted-by":"crossref","unstructured":"J. S. Hauptman et al., \u201cChallenges in linear accelerator radiotherapy for chordomas and chondrosarcomas of the skull base: focus on complications,\u201d Int J Radiat Oncol Biol Phys, vol. 83, no. 2, Art. no. 2, Jun. 2012, doi: 10.1016\/j.ijrobp.2011.08.004.","DOI":"10.1016\/j.ijrobp.2011.08.004"},{"key":"10.1016\/j.ctro.2024.100900_b0285","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/1748-717X-7-179","article-title":"Compromised quality of life in adult patients who have received a radiation dose towards the basal part of the brain. A case-control study in long-term survivors from cancer in the head and neck region","volume":"7","author":"L\u00f6fdahl","year":"2012","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ctro.2024.100900_b0290","doi-asserted-by":"crossref","unstructured":"S. H. Ipekci, M. Cakir, A. Kiyici, O. Koc, and M. Artac, \u201cRadiotherapy-induced hypopituitarism in nasopharyngeal carcinoma: the tip of an iceberg,\u201d Exp Clin Endocrinol Diabetes, vol. 123, no. 7, Art. no. 7, Jul. 2015, doi: 10.1055\/s-0035-1549963.","DOI":"10.1055\/s-0035-1549963"},{"key":"10.1016\/j.ctro.2024.100900_b0295","doi-asserted-by":"crossref","unstructured":"R. L. Jensen, P. R. Jensen, A. F. Shrieve, L. Hazard, and D. C. Shrieve, \u201cOverall and progression-free survival and visual and endocrine outcomes for patients with parasellar lesions treated with intensity-modulated stereotactic radiosurgery,\u201d J Neurooncol, vol. 98, no. 2, Art. no. 2, Jun. 2010, doi: 10.1007\/s11060-010-0174-0.","DOI":"10.1007\/s11060-010-0174-0"}],"container-title":["Clinical and Translational Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630824001770?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630824001770?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,29]],"date-time":"2025-06-29T16:28:24Z","timestamp":1751214504000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405630824001770"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":59,"alternative-id":["S2405630824001770"],"URL":"https:\/\/doi.org\/10.1016\/j.ctro.2024.100900","relation":{},"ISSN":["2405-6308"],"issn-type":[{"value":"2405-6308","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiotherapy-induced Hypothalamic-Pituitary axis dysfunction in adult Brain, head and neck and skull base tumor patients \u2013 A systematic review and Meta-Analysis","name":"articletitle","label":"Article Title"},{"value":"Clinical and Translational Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctro.2024.100900","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.","name":"copyright","label":"Copyright"}],"article-number":"100900"}}